Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports
Case Report
[키워드] acute respiratory syndrome
Admission
antibody
approach
Autoimmune disease
BNT162b2 vaccine
Case report
caused
condition
coronavirus
coronavirus disease
Coronavirus disease 2019
Corticosteroids
dermatomyositis
diagnosed
East Asian
elevated
Evidence
facial
first dose
Idiopathic inflammatory myopathies
Inflammation
Inflammatory
Intravenous immunoglobulin
intravenous methylprednisolone
lack
mechanism
Messenger ribonucleic acid vaccine
myopathies
of BNT162b2
offer
pandemic
pathophysiology
Patient
Pfizer
positive
Prednisolone
proximal
question
raise
Rash
reached
receiving
reported
second dose
severe acute respiratory syndrome coronavirus 2
South
tested
the disease
the timing
the vaccine
therapy
torso
treated
Vaccine
Vaccines
worsening
[DOI] 10.1186/s13256-022-03266-1 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s13256-022-03266-1 PMC 바로가기 [Article Type] Case Report